Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Physicians' liability for adverse drug reactions

M B Kaufman1, C A Stoukides, N A Campbell

  • 1University of Rhode Island Drug Information Center, Roger Williams Medical Center, Providence.

Southern Medical Journal
|August 1, 1994
PubMed
Summary

Physicians fear litigation when reporting adverse drug reactions, leading to low reporting rates. Understanding liability and informed consent can help prevent malpractice related to drug safety.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vacuolar reorganization in the motor cells of Albizzia during leaf movement.

Planta·2013
Same author

Dimercaptosuccinic acid loading test for assessing mercury burden in healthy individuals.

Annals of clinical biochemistry·2004
Same author

A non-class I MHC intestinal epithelial surface glycoprotein, gp180, binds to CD8.

Clinical immunology (Orlando, Fla.)·2002
Same author

Goat-associated Q fever: a new disease in Newfoundland.

Emerging infectious diseases·2001
Same author

Proton pump inhibitor therapy: preliminary results of a therapeutic interchange program.

The American journal of managed care·2000
Same author

Secondary prevention in a cardiology group practice and hospital setting after a heart-care initiative.

The American journal of cardiology·2000

Area of Science:

  • Medical Law
  • Pharmacovigilance
  • Patient Safety

Background:

  • The Food and Drug Administration's adverse drug reaction reporting system has collected data since 1960.
  • Low reporting rates of adverse drug reactions persist despite the system's longevity.
  • Physicians' apprehension regarding litigation is a significant perceived barrier to reporting.

Purpose of the Study:

  • To explore the legal underpinnings of physician liability concerning adverse drug reactions.
  • To review the standard of care in medical malpractice cases involving adverse drug events.
  • To identify strategies for physicians to mitigate malpractice risks associated with adverse drug reactions.

Main Methods:

  • Discussion of legal principles governing physician liability.

Related Experiment Videos

  • Analysis of the "standard of care" in adverse drug reaction contexts.
  • Examination of professional negligence elements and informed consent doctrines.

    • Main Results:

    • Physicians' fear of litigation is a key factor in underreporting adverse drug reactions.
    • Understanding legal standards and informed consent is crucial for managing liability.
    • Specific actions can be taken by physicians to reduce malpractice risks.

    Conclusions:

    • Addressing physicians' litigation fears is essential for improving pharmacovigilance.
    • Adherence to informed consent and understanding of professional negligence can protect physicians.
    • Enhanced reporting of adverse drug reactions contributes to overall patient safety and drug efficacy.